By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems has filed for the potential sale of more than 112 million shares of its common stock by its stockholders.

In a Form S-1 filed with the US Securities and Exchange Commission on Tuesday, WaferGen said it will not receive proceeds from the offering, but will receive $34.8 million if warrants included in the offering are exercised in full. Those funds would be used for working capital and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.